Clinical Scorecard: Building the Myopia Toolbox
At a Glance
| Category | Detail |
|---|---|
| Condition | Myopia |
| Key Mechanisms | Technologies to correct vision and slow myopia progression through specialized lens designs. |
| Target Population | Children ages 6 to 12 for various myopia management solutions. |
| Care Setting | Eyecare practices offering myopia management solutions. |
Key Highlights
- First FDA-approved technologies for myopia management include contact lenses and spectacle lenses.
- CooperVision MiSight 1 day lens shows 59% reduction in myopia progression over 3 years.
- Essilor Stellest lenses utilize H.A.L.T. technology to slow eye growth in children.
- Acuvue Abiliti Overnight lenses reduce axial elongation by 0.28 mm over 2 years.
- Innovations aim to integrate myopia management into familiar eyewear formats.
Guideline-Based Recommendations
Diagnosis
- Assess myopia progression in children regularly.
Management
- Consider FDA-approved lenses for myopia management in children.
Monitoring & Follow-up
- Monitor axial elongation and visual acuity in children using myopia management solutions.
Risks
- Evaluate potential risks associated with contact lens wear and fitting.
Patient & Prescribing Data
Children aged 6 to 12 with progressive myopia.
FDA-approved lenses provide options for both vision correction and myopia management.
Clinical Best Practices
- Utilize personalized fitting processes for orthokeratology lenses.
- Incorporate myopia management discussions during routine eye exams for children.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.